Digital Biomarkers Market: By Products (Watches, Bands, wearable injectors, Textiles), By Application (Drug Discovery and Development, Personalised Medicine, Diagnosis, Others), By End-users (Hospitals, CRO, Research Laboratories, Diagnostic Centers), By Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Digital Biomarkers Market size is valued at USD 1,243.3 million in 2022 and is expected to reach USD 1442.45 million by 2029, at a CAGR of 41.12% during the forecast period 2023-2029. Biomarkers are objective assessments that capture physiological, anatomic, and pathological aspects of an individual in order to understand the person's state and the body's warning signs. Digital biomarkers are measurable behavioural and physiological data collected and assessed using digital devices including wearables, digestibles, implantables, and portables. Digital biomarkers help to provide increased imaging capabilities as well as improved spatial resolution. Stomach aortic aneurysm, aortic analyzation, difficult fringe vein ailment, and carotid conduit sickness are among the services provided by digital biomarkers. Digital biomarkers are physiological and behavioural data that are gathered and measured using digital devices such as portables, wearables, implantables, or digestibles. Typically, the information gathered is utilised to explain, affect, and/or forecast health-related outcomes.  this report studies global Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Digital Biomarkers Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Digital Biomarkers Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). 

Digital Biomarkers Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

41.12%

Largest Market

North-America

Fastest Growing Market

Europe
Digital Biomarkers Market Dynamics

An increase in the use of connected digital devices and health-related mobile applications can be credited to the growth of the digital biomarkers industry. These devices can help with a variety of diagnostic and prognostic assessments in a variety of illness areas, such as mental health, diabetes, neurological diseases, and cardiovascular diseases. The digital biomarkers industry is being boosted by the increasing use of smartphones and the introduction of smartwatches, which aid in tracking physiological parameters of a person's health. The digital biomarkers industry is being propelled forward by technological advancements in mobile phones and digitally connected technology.

Key Features of the Reports

  • Global Digital Biomarkers Market expanding at significant CAGR over 2023 to 2029 owing to growing demand for detergents globally
  • Based on form, Product segment accounted for larger market revenue share in 2021 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global sodium silicate market

Digital Biomarkers Market Segmentation

By Product
  • Watches
  • Bands
  • wearable injectors
  • Textiles
By Application
  • Drug Discovery and Development
  • Personalised Medicine
  • Diagnosis
  • Others
By End User
  • Hospitals
  • CRO
  • Research Laboratories
  • Diagnostic Centers

Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Digital Biomarkers Market size is valued at USD 1,243.3 million in 2022 and is expected to reach USD 1442.45 million by 2029, at a CAGR of 41.12% during the forecast period 2023-2029.

The Digital Biomarkers Market is experiencing a growing trend of leveraging wearable devices and digital health technologies to monitor and analyze patients' health data for disease management and treatment optimization.

1.Executive Summary
2.Global Digital Biomarkers Market Introduction 
2.1.Global Digital Biomarkers Market  - Taxonomy
2.2.Global Digital Biomarkers Market  - Definitions
2.2.1.Product
2.2.2.Application
2.2.3.End User
2.2.4.Region
3.Global Digital Biomarkers Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Digital Biomarkers Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Digital Biomarkers Market  By Product, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Watches
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Bands
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. wearable injectors
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Textiles
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Digital Biomarkers Market  By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Drug Discovery and Development
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Personalised Medicine
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Diagnosis
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Digital Biomarkers Market  By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. CRO
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Research Laboratories
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Diagnostic Centers
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Digital Biomarkers Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Digital Biomarkers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Product Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Watches
9.1.2.Bands
9.1.3.wearable injectors
9.1.4.Textiles
9.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Drug Discovery and Development
9.2.2.Personalised Medicine
9.2.3.Diagnosis
9.2.4.Others
9.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.CRO
9.3.3.Research Laboratories
9.3.4.Diagnostic Centers
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Digital Biomarkers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Watches
10.1.2.Bands
10.1.3.wearable injectors
10.1.4.Textiles
10.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Drug Discovery and Development
10.2.2.Personalised Medicine
10.2.3.Diagnosis
10.2.4.Others
10.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.CRO
10.3.3.Research Laboratories
10.3.4.Diagnostic Centers
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
10.4.7.
11.Asia Pacific (APAC) Digital Biomarkers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Watches
11.1.2.Bands
11.1.3.wearable injectors
11.1.4.Textiles
11.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Drug Discovery and Development
11.2.2.Personalised Medicine
11.2.3.Diagnosis
11.2.4.Others
11.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.CRO
11.3.3.Research Laboratories
11.3.4.Diagnostic Centers
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Digital Biomarkers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Watches
12.1.2.Bands
12.1.3.wearable injectors
12.1.4.Textiles
12.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Drug Discovery and Development
12.2.2.Personalised Medicine
12.2.3.Diagnosis
12.2.4.Others
12.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.CRO
12.3.3.Research Laboratories
12.3.4.Diagnostic Centers
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Digital Biomarkers Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Watches
13.1.2.Bands
13.1.3.wearable injectors
13.1.4.Textiles
13.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Drug Discovery and Development
13.2.2.Personalised Medicine
13.2.3.Diagnosis
13.2.4.Others
13.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.CRO
13.3.3.Research Laboratories
13.3.4.Diagnostic Centers
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.The Hague I B.V. (Affymetrix Inc.)
14.2.2.Abbott Laboratories
14.2.3.Hoffmann-La Roche Ltd.
14.2.4.AbbVie Inc.
14.2.5.Arquer Diagnostics Ltd.
14.2.6.Illumina, Inc.
14.2.7.Qiagen (Germany)
14.2.8.Agilent Technologies.
14.2.9.Merck & Co. Inc.
14.2.10.Becton Dickinson and Company.
14.2.11.Hologic Inc.
15. Research Methodology 
16. Appendix and Abbreviations 
  • The Hague I B.V. (Affymetrix Inc.)
  • Abbott Laboratories
  • Hoffmann-La Roche Ltd.
  • AbbVie Inc.
  • Arquer Diagnostics Ltd.
  • Illumina, Inc.
  • Qiagen (Germany)
  • Agilent Technologies.
  • Merck & Co. Inc.
  • Becton Dickinson and Company.
  • Hologic Inc.

Adjacent Markets